Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (321-330 of 345) with videos related to

Pageof 35
Sort By:
The Lancet. Oncology|December 25, 2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trialMartin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, et al.
Neuro-Oncology|October 23, 2024
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directionsMary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, et al.
Neuro-Oncology|April 29, 2021
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic gliomaC Mircea S Tesileanu, Martin J van den Bent, Marc Sanson, et al.
Journal of Neuro-Oncology|March 1, 2024
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumorsJames L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Pageof 35

Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
The Lancet. Oncology|December 25, 2025
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trialMartin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, et al.
Neuro-Oncology|October 23, 2024
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directionsMary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, et al.
Neuro-Oncology|April 29, 2021
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic gliomaC Mircea S Tesileanu, Martin J van den Bent, Marc Sanson, et al.
Journal of Neuro-Oncology|March 1, 2024
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumorsJames L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Pageof 35